Cantor Fitzgerald Reiterates Overweight on Merck & Co, Maintains $155 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Merck & Co (NYSE:MRK) and maintained a price target of $155.
September 16, 2024 | 4:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald's analyst Louise Chen has reiterated an Overweight rating on Merck & Co, maintaining a price target of $155, indicating confidence in the company's stock performance.
The reiteration of an Overweight rating and a maintained price target of $155 by a reputable analyst suggests a positive outlook for Merck & Co's stock. This could lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100